1/30
07:43 am
athe
Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update [Yahoo! Finance]
Medium
Report
Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update [Yahoo! Finance]
1/30
07:25 am
athe
Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update
Low
Report
Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update
1/21
07:25 am
athe
Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026
Medium
Report
Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026
12/17
08:05 am
athe
Alterity Therapeutics (NASDAQ:ATHE) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "speculative buy" rating on the stock.
Medium
Report
Alterity Therapeutics (NASDAQ:ATHE) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "speculative buy" rating on the stock.
11/12
07:43 am
athe
Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference [Yahoo! Finance]
Low
Report
Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference [Yahoo! Finance]
11/12
07:25 am
athe
Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference
Low
Report
Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference